Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Wallentin, L; Lopes, RD; Hanna, M; Thomas, L; Hellkamp, A; Nepal, S; Hylek, EM; Al-Khatib, SM; Alexander, JH; Alings, M; Amerena, J; Ansell, J; Aylward, P; Bartunek, J; Commerford, P; De Caterina, R; Erol, C; Harjola, V-P; Held, C; Horowitz, J; Huber, K; Husted, S; Keltai, M; Lanas, F; Lisheng, L; McMurray, JJV; Oh, B-H; Rosenqvist, M; Ruzyllo, W; Steg, PG; Vinereanu, D; Xavier, D; Granger, CB

Published Date

  • January 14, 2014

Published In

Volume / Issue

  • 129 / 2

Start / End Page

  • e21 - e22

PubMed ID

  • 24421367

Pubmed Central ID

  • 24421367

Electronic International Standard Serial Number (EISSN)

  • 1524-4539

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.113.005709

Language

  • eng

Conference Location

  • United States